| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |